French National Observatory of Patients With Thymic Epithelial Tumor

计划入组 3,262 人 · 首次发布于 2016 年 3 月 31 日

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

计划入组 100 人 · 首次发布于 2024 年 11 月 18 日

Molecular Analysis and Treatment Options of Thymic Malignancies

计划入组 500 人 · 首次发布于 2022 年 12 月 29 日

Amniotic Epithelial Cells

autologous tumor-infiltrating lymphocyte therapy (iv, advanced epithelial tumors/solid tumors)

Thymoctonan

Stiftung Swiss Tumor Institute

Switzerland

National Center for Tumor Diseases

Germany

The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital)

China

Henlius' PD-L1 ADC HLX43 Receives FDA Orphan Drug Designation for Thymic Epithelial Tumors

Elevar Therapeutics to Present Three Abstracts at ESMO 2026, Including Phase 2 THRIVE Trial of Rivoceranib in Thymic Tumors

Novel Immunotherapy Combinations Show Promise in Advanced Thymic Cancers